Author page: Kathrin Folkendt

Women’s Health Research Round-up (July 1, 2024)

In recent years, there has been a significant increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies and their contributions to understanding and advancing women’s health. This round-up was created with help from our very own Femtech Bot. We welcome your feedback on…

Polari Group Secures $539K Pre-Seed Funding to Advance Anal Health and Pleasure

Polari Group has secured $539K in pre-seed funding to advance their work in anal health and pleasure. The funding round was supported by Ventures Together, Ada Ventures (Ada Angel Program), Chasing Rainbows, Little Green Bamboo Capital, and a series of international angel investors. Founded in 2023 by bioengineer Anna Vybornova and chemist and immunologist Dr. Henry Blest, Polari Group aims to improve…

Women’s Health Research Round-up (June 24, 2024)

In recent years, there has been a significant increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies and their contributions to understanding and advancing women’s health. This round-up was created with help from our very own Femtech Bot. We welcome your feedback on…

Elvie Expands into Digital Health with New Pelvic Floor Training App

Elvie, a leader in consumer health devices, is stepping into the digital health arena with the launch of Elvie Strong, a free app designed to support pelvic floor health. This is Elvie’s first venture into purely digital solutions, aiming to make health and wellness more accessible for women. Pelvic floor muscles are vital for overall health, impacting bladder control and sexual function.…

Women’s Health Research Round-up (June 17, 2024)

In recent years, there has been a significant increase in research focusing on women’s health, addressing various conditions, and exploring innovative solutions to improve health outcomes. This round-up article presents an overview of the latest studies and their contributions to understanding and advancing women’s health. This round-up was created with help from our very own Femtech Bot. We welcome your feedback on…

Amber Therapeutics Secures $100M Series A Funding for Neuromodulation Therapy for Mixed Urinary Incontinence

Amber Therapeutics, a UK-based medical technology company, has successfully closed a $100 million Series A financing round. The investment will advance their Amber-UI neuromodulation therapy towards US FDA approval. The financing round, one of the largest ever in Europe for a medical technology company, was led by New Enterprise Associates (NEA) with participation from F-Prime Capital, Lightstone Ventures, Intuitive Ventures, and existing…